UPLC-HR-ESI-MS ANALYSIS AND ANTIPROLIFERATIVE AND ANTI-DIABESITY SCREENING OF FLOWERS, ROOTS, AND AERIAL PARTS OF SOLANUM ELAEAGNIFOLIUM CAV.

Authors

  • KHAWLA DHAMEN AL-HAMAIDEH Department of Basic Medical Sciences, Faculty of Medicine, Al-Balqa Applied University, Al-Salt-19117, Jordan https://orcid.org/0000-0002-7437-0253

DOI:

https://doi.org/10.22159/ijap.2023v15i6.49273

Keywords:

Aerial parts, Colorectal cancer, Flowers, Obesity, Roots, Solanum elaeagnifolium Cav., UPLC-MS

Abstract

Objective: Solanum elaeagnifolium Cav. is an invasive summer-growing wild perennial herb but is traditionally used to treat some health conditions, including toothache and constipation. This study aimed to identify the chemical composition of various parts of this herb (flowers, roots, and aerial parts) and explore its biological properties.

Methods: Ultra-Performance Liquid Chromatography-Mass Spectrometry (UPLC-MS) was used for the first time for the root to analyze the hydro-alcoholic extract besides flowers and aerial parts of S. elaeagnifolium. Sulforhodamine B (SRB) assay was used to assess the antiproliferative effects of the same extracts on the colorectal cancer cell lines (CACO2, SW620, HT29, and HCT116). The aqueous extracts of the plant’s three parts were evaluated in vitro for their anti-diabesity properties.

Results: For the first time, other compounds in three plant parts were identified using UPLC-MS: hyperoside and apigenin (flavonoids), in flowers and roots, naringin (flavonoid) in the roots, and apigenin (flavonoid) in aerial parts, diosgenin (steroids sapogenin) solamargine, and solasodine (alkaloids) in the three parts. In addition to the previously identified compounds; chlorogenic acid and kaempferol were in the aerial part, and flowers; and luteolin (flavonoids) were in the aerial parts. Pharmacologically, the aqueous extracts of flowers and roots proved anti-diabesity activity, and no anti-proliferative effect was detected for their hydro-alcoholic extracts. Neither anti-obesity nor anti-proliferative activities were detected in the aerial part extracts. 

Conclusion: Further in vivo and in vitro investigations are required for the different parts of S. elaeagnifolium to explore more biological activities and evaluate the plant’s toxicity.

Downloads

Download data is not yet available.

References

Spinelli A, Buoncristiano M, Nardone P, Starc G, Hejgaard T, Juliusson PB. Thinness, overweight, and obesity in 6 to 9 y old children from 36 countries: The World Health Organization European Childhood Obesity Surveillance Initiative-COSI 2015-2017. Obes Rev. 2021;22Suppl 6:e13214. doi: 10.1111/obr.13214, PMID 34235850.

Peng W, Zhang J, Zhou H, Zhang A, Wang Y, Tian X. Obesity intervention efforts in China and the 2022 world obesity day. Global Health Journal. 2022;6(3):118-21. doi: 10.1016/j.glohj.2022.07.007.

Sarkar S, Sadhu S, Roy R, Tarafdar S, Mukherjee N, Sil M. Contemporary drifts in diabetes management. Int J App Pharm. 2023;15:1-9. doi: 10.22159/ijap.2023v15i2.46792.

Rudrapal M, Khairnar SJ, Khan J, Dukhyil AB, Ansari MA, Alomary MN. Dietary polyphenols and their role in oxidative stress-induced human diseases: insights into protective effects, antioxidant potentials and mechanism(s) of action. Front Pharmacol. 2022;13:806470. doi: 10.3389/fphar.2022.806470, PMID 35237163.

Rana A, Samtiya M, Dhewa T, Mishra V, Aluko RE. Health benefits of polyphenols: a concise review. J Food Biochem. 2022;46(10):e14264. doi: 10.1111/jfbc.14264, PMID 35694805.

Qudah SAA, Al-Hamaideh KD, Dmour IM, Al Sbaihi SS. Overweight management: a cross-sectional study with special insight on metformin use in obesity control. J Appl Pharm Sci. 2022;12(8):179-86.

Al-Hamaideh KD, Dmour IM. Diuretics misuse: a cross-sectional study to explore community pharmacist’s perceptions of diuretics use and misuse. J Appl Pharm Sci. 2023;13(6):128-36. doi: 10.7324/JAPS.2023.104335.

Dmour IM, Al-Hamaideh KD, Qudah SAA, Al-Shawabkeh JD. Self-care interventions among the Jordanians during the COVID-19 lockdown: a cross-sectional study of community pharmacists’ observations. J Appl Pharm Sci. 2023;13(9). doi: 10.7324/JAPS.2023.143803.

Bhardwaj M, Yadav P, Vashishth D, Sharma K, Kumar A, Chahal J. A review on obesity management through natural compounds and a green nanomedicine-based approach. Molecules. 2021;26(11):3278. doi: 10.3390/molecules26113278, PMID 34071722.

Khutami C, Sumiwi SA, Khairul Ikram NK, Muchtaridi M. The effects of antioxidants from natural products on obesity, dyslipidemia, diabetes and their molecular signaling mechanism. Int J Mol Sci. 2022;23(4):2056. doi: 10.3390/ijms23042056, PMID 35216172.

Karri S, Sharma S, Hatware K, Patil K. Natural anti-obesity agents and their therapeutic role in management of obesity: a future trend perspective. Biomed Pharmacother. 2019;110:224-38. doi: 10.1016/j.biopha.2018.11.076, PMID 30481727.

Jaradat N, Zaid AN, Hussein F, Zaqzouq M, Aljammal H, Ayesh O. Anti-lipase potential of the organic and aqueous extracts of ten traditional edible and medicinal plants in Palestine; a comparison study with orlistat. Medicines (Basel, Switzerland). 2017;4(4). doi: 10.3390/medicines4040089, PMID 29292744.

Kandimalla R, Kalita S, Choudhury B, Kotoky J. A review on anti-diabetic potential of genus Solanum (solanaceae). J Drug Delivery Ther 2015;5(1):24-7. doi: 10.22270/jddt.v5i1.1026.

Sharour LA, Omari OA, Salameh AB, Yehia D. Health-related quality of life among patients with colorectal cancer. J Res Nurs. 2020;25(2):114-25. doi: 10.1177/1744987119846177, PMID 34394615.

Alaryani FS, Turki Alrdahe SS. A review of treatment, risk factors, and incidence of colorectal cancer. Int J App Pharm. 2022;14(1):1-6. doi: 10.22159/ijap.2022v14i1.42820.

Agraib LM, Al-Shorman A, Salah S. Abu-hijlih R, Abuhijla F. The effect of probiotics supplementation on the side effects of chemoradiotherapy for colorectal cancer: a literature review. Onkol Radioter. 2020;14(4):43-51.

Al-Hamaideh KD, Dmour I, El-Elimat T, Afifi FU. UPLC-MS profile and anti-proliferative activity of the berries of an aggressive wild-growing weed: Solanum elaeagnifolium Cav. (Solanaceae). Nat Prod Res. 2020;4(12):1131-38. doi: 10.26538/tjnpr/v4i12.

AL-Hamaideh KD, El-Elimat T, Afifi FU, Kasabri V. Phytochemical screening and pharmacological activities of Echium judaeum Lacaita extracts growing wild in Jordan. J Appl Pharm Sci. 2017;10(3):153-64.

Abu Odeh A, Fino L, Al-Absi G, Alnatour D, Al-Darraji M, Shehadeh M. Medicinal plants of Jordan: scoping review. Heliyon. 2023;9(6):e17081. doi: 10.1016/j.heliyon.2023.e17081, PMID 37332946.

Al-Daghistani HI, Abu-Niaaj LF, Bustanji Y, Al-Hamaideh KD, Al-Salamat H, Nassar MN. Antibacterial and cytotoxicity evaluation of Arum hygrophilum bioss. Eur Rev Med Pharmacol Sci. 2021;25(23):7306-16. doi: 10.26355/eurrev_202112_27424, PMID 34919230.

Jaber HM, Al-Hamaideh KD, Al-Daghistani HI, Amer NH, Nassar MN, Al-Latif A. Antibacterial activity and chemical composition of Arum hygrophilum boiss crude extracts. Jordan J Biol Sci. 2020;13(2):159-64.

Al-Eisawi D. Taxonomic synopsis of Brassicaceae for the flora of Jordan. Webbia. 2016;71(2):219-26. doi: 10.1080/00837792.2016.1184393.

Roberts J, Florentine S. Biology, distribution and management of the globally invasive weed Solanum Elaeagnifolium Cav. (silverleaf nightshade): a global review of current and future management challenges. Weed Res. 2022;62(6):393-403. doi: 10.1111/wre.12556.

Kaunda JS, Zhang YJ. The genus Solanum: an ethnopharmacological, phytochemical and biological properties review. Nat Prod Bioprospect. 2019;9(2):77-137. doi: 10.1007/s13659-019-0201-6, PMID 30868423.

Badawy A, Zayed R, Ahmed S, Hassanean H. Phytochemical and pharmacological studies of Solanum elaeagnifolium growing in Egypt. J Nat Prod. 2013;6:156-67.

Lee KR, Kozukue N, Han JS, Park JH, Chang EY, Baek EJ. Glycoalkaloids and metabolites inhibit the growth of human colon (HT29) and liver (HEPG2) cancer cells. J Agric Food Chem. 2004;52(10):2832-9. doi: 10.1021/jf030526d, PMID 15137822.

Singleton JJ, Mangat PK, Shim J, Vavra C, Coldren C, Angeles Shim RB. Cross-species transferability of Solanum spp. DNA markers and their application in assessing genetic variation in silverleaf nightshade (Solanum elaeagnifolium) populations from Texas, USA. Weed Sci. 2020;68(4):396-404. doi: 10.1017/wsc.2020.25.

Qasem JR, Al Abdallat AM, Hasan SM. Genetic diversity of Solanum elaeagnifolium, an invasive problematic weed in Jordan. Weed Res. 2019;59(3):222-34. doi: 10.1111/wre.12360.

Salmane BG, Bouhache M, Birouk A, Marie Claude B. Macromorphological variation of the invasive silverleaf nightshade (Solanum elaeagnifolium Cav.) and its relation to climate and altitude in morocco. Rev Maroc Sci Agron Vet. 2019;7(2):243-51.

El-Elimat T, Figueroa M, Ehrmann BM, Cech NB, Pearce CJ, Oberlies NH. High-resolution MS, MS/MS, and UV database of fungal secondary metabolites as a dereplication protocol for bioactive natural products. J Nat Prod. 2013;76(9):1709-16. doi: 10.1021/np4004307, PMID 23947912.

Bouslamti M, Loukili EH, Elrherabi A, El Moussaoui A, Chebaibi M, Bencheikh N. Phenolic profile, inhibition of α-amylase and α-glucosidase enzymes, and antioxidant properties of Solanum elaeagnifolium cav. (Solanaceae): In vitro and in silico investigations. Processes. 2023;11(5):1384. doi: 10.3390/pr11051384.

Sathiyamoorthy P, Lugasi Evgi H, Schlesinger P, Kedar I, Gopas J, Pollack Y. Screening for cytotoxic and antimalarial activities in desert plants of the Negev and Bedouin market plant products. Pharm Biol. 1999;37(3):188-95. doi: 10.1076/phbi.37.3.188.6298.

Radwan MM, Badawy A, Zayed R, Hassanin H, ElSohly MA, Ahmed SA. Cytotoxic flavone glycosides from Solanum elaeagnifolium. Med Chem Res. 2015;24(3):1326-30. doi: 10.1007/s00044-014-1219-2.

Chidambaram K, Alqahtani T, Alghazwani Y, Aldahish A, Annadurai S, Venkatesan K. Medicinal plants of Solanum species: the promising sources of phyto-insecticidal compounds. J Trop Med. 2022;2022:4952221. doi: 10.1155/2022/4952221, PMID 36187457.

Stabrauskiene J, Kopustinskiene DM, Lazauskas R, Bernatoniene J. Naringin and naringenin: their mechanisms of action and the potential anticancer activities. Biomedicines. 2022;10(7):1686. doi: 10.3390/biomedicines10071686, PMID 35884991.

Xavier TF, Sabitha R, Kariyat R, Rose AKF, Ayyanar M, Subramaniyan V. In vitro and in silico strategies to assess the unexplored pharmacological lineages of Solanum elaeagnifolium Cav. Leaves. 2022;1-25. doi: 10.21203/rs.3.rs-2042266/v1

Fan Y, Li Z, Wu L, Lin F, Shao J, Ma X. Solasodine, isolated from Solanum sisymbriifolium fruits, has a potent anti-tumor activity against pancreatic cancer. Drug Des Devel Ther. 2021;15:1509-19. doi: 10.2147/DDDT.S266746, PMID 33888977.

Published

07-11-2023

How to Cite

AL-HAMAIDEH, K. D. (2023). UPLC-HR-ESI-MS ANALYSIS AND ANTIPROLIFERATIVE AND ANTI-DIABESITY SCREENING OF FLOWERS, ROOTS, AND AERIAL PARTS OF SOLANUM ELAEAGNIFOLIUM CAV. International Journal of Applied Pharmaceutics, 15(6), 256–263. https://doi.org/10.22159/ijap.2023v15i6.49273

Issue

Section

Original Article(s)